Emerging Policy Response Resources / Government & Legislative Affairs / Tariffs

AdvaMed® Advancements: Q3 2025 Report

AdvaMed® Advancements: Q3 2025 Report. Amid an increasingly charged political environment, AdvaMed remained a steady, persuasive voice for medtech innovation. From mobilizing rapid action on the Section 232 investigation to…

Cover of the AdvaMed and Frost & Sullivan report titled “The Economic Impact of the Medical Technology Industry” showing a masked healthcare professional in surgical attire with the text “Driving Innovation in Medtech.”
Emerging Policy Response Resources / Government & Legislative Affairs / Tariffs / Workforce Advancement

The Economic Impact of the Medical Technology Industry 2024

Explore AdvaMed’s 2024 Economic Impact Report, developed by Frost & Sullivan, highlighting medtech’s vital contributions to the U.S. economy

Coverage & Payment / Diabetes / Diagnostics / Digital Health / Government & Legislative Affairs / Health Access

AdvaMed Welcomes CMS’ Rural Health Transformation Program

WASHINGTON—AdvaMed, the medtech association, welcomed today’s CMS’ announcement of the details of the $50 billion Rural Health Transformation Program. This program gives states the chance to access the latest health…

Coverage & Payment / Diagnostics / Government & Legislative Affairs / Health Access

AdvaMed Welcomes Bipartisan Bill to Support Patient Access to Laboratory Testing

WASHINGTON—AdvaMed, the medtech association, today welcomed the introduction in the U.S. House of Representatives and Senate of the bipartisan Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act…